OHE Publications

OHE releases a number of publications throughout the year, authored by OHE team members and/or outside experts. All are free for download as pdf files; hard copies of some publications are available upon request.

A description of the OHE publications categories.


 

Donaldson, C.

Seminar Briefing
November 2011

Because health care resources always are scarce, decisions about what (and what not) to pay for cannot be avoided. Deciding how to value health and aspects of health care continue to be the subject of much debate. In this Briefing, Prof Donaldson takes a thorough look at the potential role of the willingess to pay (WTP) approach as a means for valuing the intangibles in health care. He examines whether more explicit monetary valuation of benefits, through elicitation of patients’ and the public’s willingness to pay, are not only useful, buy feasible and defensible in

Feng, Y., Farrar, S., Sutton, M. and May, A.

Research Paper
November 2011

This paper investigates how the increased rate of Quality and Outcomes Framework (QOF) payments implemented on 1 April 2005 affects Scottish general practitioners’ (GPs) intrinsic, extrinsic and overall motivation. A first difference method is used to model GPs’ intrinsic and overall motivation. The main finding is that the increased QOF payment effectively motivated GPs' health care supply, but it also 'crowded out' GPs' intrinsic motivation.

Richards, M.

Monograph
July 2011

The speaker for the OHE's 16th Annual Lecture was Sir Mike Richards, National Clinical Director for Cancer and End of Life Care in England's Department of Health.

In his presentation, Prof Richards addressed five questions about the NHS achieving world class outcomes in cancer: (1) What would ‘world class’ look like (2) What measures are appropriate? (3) Where are we now? (4) Why are England's outcomes below the best? and (5) What do we need to do to close the gap?

Shah, K., Praet, C., Devlin, N., Sussex, J., Appleby, J. and Parkin, D.

Research Paper
May 2011

The appraisal of health care technologies by the UK’s National Institute for Health and Clinical Excellent (NICE) focuses on cost effectiveness, usually measured in terms of incremental cost per quality adjusted life year (QALY) gained.  According to the findings presented in this Research Paper, however, cost effectiveness does not appear to be the dominant consideration in NHS decisions about resource allocation.

Garau, M., Mordoh, A. and Sussex, J.

Consulting Report
April 2011

Continuing concern about the fiscal deficit makes it likely that government funding of health and medical research will remain under scrutiny. This OHE Consulting study, commissioned by Cancer Research UK, explores the interdependence between publicly funded and charity funded medical research.  In particular, it focuses on whether and how changes in the levels of government funding can affect private funding for charities, medical research and the UK economy as a whole.

Watson, V., Sussex, J., Teeteh, E. and Ryan, M.

Research Paper
March 2011

The UK’s National Clinical Assessment Agency (NCAS) is designed specifically to provide advice on performance issues, on request, to NHS organisations employing or contracting with doctors, pharmacists, and dentists. Currently, the NCAS is financed from central NHS funds, not from charges to NHS organisations. By 2013, however, the NCAS is to become self-funding.

Martin, B.

Seminar Briefing
December 2010

Professor Ben Martin (Science and Technology Policy Studies at SPRU, University of Sussex) defines science policy research as ‘economic, policy, management and organisational studies of science, technology and innovation (STI) with a view to providing useful inputs to decision-makers concerned with policies for and the management of STI’.  The field is important because STI is important: it is a source of progress, a major contributor to the wealth of nations, provides the basis for new goods and services and for new capabilities, and contributes to changes in the quality of life and t

Mestre-Ferrandiz, J., Garau, M., O'Neill, P. and Sussex, J.

Consulting Report
November 2010

This report examines the effect of the European Union’s 1999 Regulation on Orphan Medicinal Products (OMPs) on the European economy and society.  This study collected data on several indicators of activity, completed a confidential survey of companies developing OMP, concluded four case studies and undertook a literature review.  The result is a rich tableau of data and information that describe the effects of the OMP Regulation in some detail.  Findings include the following.

O'Neill, P.

Monograph
November 2010

In December 2006, the National Institute for Health and Clinical Excellence (NICE) issued guidance for preventing and managing overweight and obesit. Recommendations are step-wise, starting with lifestyle changes and progressing through medicine to bariatric surgery. The guidance recommends that patients considered for bariatric surgery have either a BMI of 40 or more, or a BMI over 35 with an associated condition such as diabetes. Costing guidelines are included in the guidance.

Pages